Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

NCT: NCT05378347 · RECRUITING

NCT IDNCT05378347
StatusRECRUITING
Start Date2023-01-05
Completion2031-05

Brief Summary

The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.

Frequently Asked Questions

What is Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial?

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial is a clinical trial registered under NCT05378347. Current status: RECRUITING.

What is the status of NCT05378347?

The current status of NCT05378347 (Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial) is: RECRUITING.

When did Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial start?

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial started on 2023-01-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑